EA201301340A1 - PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE ACTION, ITS APPLICATION AND METHODS TO IMPROVE VIABILITY AND PREVENTION OR TREATMENT OF CEREBROVASCULAR AND NEURODEGENERATIVE TREATMENTS. - Google Patents
PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE ACTION, ITS APPLICATION AND METHODS TO IMPROVE VIABILITY AND PREVENTION OR TREATMENT OF CEREBROVASCULAR AND NEURODEGENERATIVE TREATMENTS.Info
- Publication number
- EA201301340A1 EA201301340A1 EA201301340A EA201301340A EA201301340A1 EA 201301340 A1 EA201301340 A1 EA 201301340A1 EA 201301340 A EA201301340 A EA 201301340A EA 201301340 A EA201301340 A EA 201301340A EA 201301340 A1 EA201301340 A1 EA 201301340A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical composition
- cerebrovascular
- prevention
- treatment
- glu
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к медицине и касается фармацевтической композиции, содержащей пептиды Asp-Glu-Gly, Lys-Asp-Glu и Ala-Asp-Glu-Leu. Композиция обладает выраженным нейропротекторным действием, что позволяет использовать фармацевтическую композицию, содержащую пептиды Ala-Asp-Glu, Lys-Asp-Glu и Ala-Asp-Glu-Leu для профилактики или лечения цереброваскулярных и нейродегенеративных заболеваний, а также для повышения жизнеспособности.The invention relates to medicine and relates to a pharmaceutical composition comprising peptides Asp-Glu-Gly, Lys-Asp-Glu and Ala-Asp-Glu-Leu. The composition has a pronounced neuroprotective effect, which allows the use of a pharmaceutical composition containing the peptides Ala-Asp-Glu, Lys-Asp-Glu and Ala-Asp-Glu-Leu for the prevention or treatment of cerebrovascular and neurodegenerative diseases, as well as to increase viability.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201301340A EA023025B1 (en) | 2013-12-26 | 2013-12-26 | Pharmaceutical composition having a neuroprotective effect, use thereof and methods for enhancing vitality and preventing and/or treating cerebrovascular and neurodegenerative diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201301340A EA023025B1 (en) | 2013-12-26 | 2013-12-26 | Pharmaceutical composition having a neuroprotective effect, use thereof and methods for enhancing vitality and preventing and/or treating cerebrovascular and neurodegenerative diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201301340A1 true EA201301340A1 (en) | 2015-06-30 |
EA023025B1 EA023025B1 (en) | 2016-04-29 |
Family
ID=53488009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201301340A EA023025B1 (en) | 2013-12-26 | 2013-12-26 | Pharmaceutical composition having a neuroprotective effect, use thereof and methods for enhancing vitality and preventing and/or treating cerebrovascular and neurodegenerative diseases |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA023025B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2678987C2 (en) * | 2017-04-28 | 2019-02-05 | Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" | Peptide for treatment of alzheimer's disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2468813C1 (en) * | 2011-08-08 | 2012-12-10 | Градстейн Инвестментс Лимитед | Agent for prevention and treatment of acute and chronic cerebrovascular disease, use and method of treating |
RU2482128C1 (en) * | 2011-12-28 | 2013-05-20 | Замертон Холдингс Лимитед | Peptides possessing cytoprotective activity |
RU2480233C1 (en) * | 2012-02-29 | 2013-04-27 | Замертон Холдингс Лимитед | Pharmaceutical composition possessing antihypoxic, neuroprotective and antiamnestic activity |
-
2013
- 2013-12-26 EA EA201301340A patent/EA023025B1/en active IP Right Revival
Also Published As
Publication number | Publication date |
---|---|
EA023025B1 (en) | 2016-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201691582A1 (en) | NEW PHARMACEUTICAL PREPARATIONS | |
EA201790932A1 (en) | DOSAGE AND ADMINISTRATION OF NONFUCULATED ANTI-CD40 ANTIBODIES | |
EA201790273A1 (en) | FLAGELLIN COMPOSITIONS AND THEIR APPLICATION | |
EA201991484A1 (en) | MEDICINAL FORMS OF ENZALUTAMIDE | |
EA201591166A1 (en) | AUTOTAXIN INHIBITORS | |
EA201591616A1 (en) | TRIFTTOROMETHYL-SUBSTITUTED ANNELATED PYRIMIDINES AND THEIR APPLICATION | |
EA201691845A1 (en) | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS | |
EA201591925A1 (en) | THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION | |
EA201790575A1 (en) | TRIAZOLOPIRASINONS AS PDE1 INHIBITORS | |
EA202090098A1 (en) | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS | |
EA201692109A1 (en) | OPTIONS OF ANTIBODIES TO FACTOR D AND THEIR APPLICATION | |
EA201790576A1 (en) | Spirocyclic inhibitors of katepsin C | |
EA201692007A1 (en) | IZOINDOLINON COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA, AND RELATED DISORDERS | |
EA201691481A1 (en) | C5a inhibitors for the treatment of viral pneumonia | |
AR101740A1 (en) | COMBINATION AND COMPOSITION THERAPY | |
EA201690159A1 (en) | METHODS AND COMPOSITIONS FOR CANCER TREATMENT | |
EA201792157A1 (en) | IMIDAZOPIRASINONS AS PDE1 INHIBITORS | |
EA201690039A1 (en) | RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION | |
PH12017500304A1 (en) | Vaccine compositions against dengue virus diseases | |
EA201690783A1 (en) | SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES | |
EA201491500A1 (en) | FIBROZA TREATMENT METHODS | |
EA201791249A1 (en) | CD44V6-RECEIVED CYCLIC PEPTIDES FOR THE TREATMENT OF MALIGNANT TUMORS AND ANGOGENESIS-ASSOCIATED DISEASES | |
CO2017001087A2 (en) | Anti angiopoietin-like protein 4 antibodies | |
EA201792571A1 (en) | THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN | |
MX2019001634A (en) | Amide compounds, pharmaceutical compositions thereof, and methods of using the same. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): KG TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ RU |
|
NF4A | Restoration of lapsed right to a eurasian patent |
Designated state(s): AM AZ BY KZ RU |
|
PC4A | Registration of transfer of a eurasian patent by assignment |